Basit öğe kaydını göster

Lamivudine monotherapy and lamivudine plus interferon alpha combination therapy in HBeAg negative chronic hepatitis B not responding to previous interferon alpha monotherapy

dc.contributor.authorBesisik, Fatih
dc.contributor.authorCakaloglu, Yilmaz
dc.contributor.authorDemir, Kadir
dc.contributor.authorAkyuz, Filiz
dc.contributor.authorOkten, Atilla
dc.contributor.authorAksoy, Nevzat
dc.contributor.authorKaraca, Cetin
dc.contributor.authorDanalioglu, Ahmet
dc.contributor.authorOnel, Derya
dc.contributor.authorBadur, Selim
dc.contributor.authorKaymakoglu, Sabahattin
dc.date.accessioned2021-03-06T10:56:56Z
dc.date.available2021-03-06T10:56:56Z
dc.date.issued2007
dc.identifier.citationAkyuz F., Kaymakoglu S., Demir K., Aksoy N., Karaca C., Danalioglu A., Onel D., Badur S., Besisik F., Cakaloglu Y., et al., "Lamivudine monotherapy and lamivudine plus interferon alpha combination therapy in HBeAg negative chronic hepatitis B not responding to previous interferon alpha monotherapy", Acta Gastro-Enterologica Belgica, cilt.70, ss.20-24, 2007
dc.identifier.issn0001-5644
dc.identifier.othervv_1032021
dc.identifier.otherav_ecc8a3cd-2ba8-4c99-995a-3c94ec8e9a1c
dc.identifier.urihttp://hdl.handle.net/20.500.12627/155448
dc.identifier.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=34247105858&origin=inward
dc.description.abstractBackground and study aims : To investigate the efficacy of the combined therapy of lamivudine (LAM) plus alpha interferon (IFN) and LAM monotherapy in HBeAg negative chronic hepatitis B (CHB) patients who were unresponsive to previous IFN monotherapy, and the incidence of YMDD mutations.
dc.language.isoeng
dc.subjectTıp
dc.subjectDahili Tıp Bilimleri
dc.subjectİç Hastalıkları
dc.subjectGastroenteroloji-(Hepatoloji)
dc.subjectSağlık Bilimleri
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectGASTROENTEROLOJİ VE HEPATOLOJİ
dc.titleLamivudine monotherapy and lamivudine plus interferon alpha combination therapy in HBeAg negative chronic hepatitis B not responding to previous interferon alpha monotherapy
dc.typeMakale
dc.relation.journalActa Gastro-Enterologica Belgica
dc.contributor.department, ,
dc.identifier.volume70
dc.identifier.issue1
dc.identifier.startpage20
dc.identifier.endpage24
dc.contributor.firstauthorID180802


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster